Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants.

CPT Pharmacometrics Syst Pharmacol · 2016 · PMC4999604 · PMID 27501453

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The sirolimus CL estimates in neonates and infants showed an increasing trend over time, after accounting for the effect of body size/growth.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.